Telemonitoring to Treat Group 2 Pulmonary Hypertension

NCT04882774 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped never opened to enrollment because it was never funded

Conditions

Pulmonary Hypertension Due to Left Heart Disease

Interventions

DRUG: Treprostinil Diolamine

Sponsor

Mardi Gomberg -Maitland MD, MSc

Collaborators

[object Object]
[object Object]